BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 25129289)

  • 1. Cardiotoxicity: anthracyclines and long term cancer survivors.
    Patanè S
    Int J Cardiol; 2014 Oct; 176(3):1326-8. PubMed ID: 25129289
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological foundations of cardio-oncology.
    Minotti G; Salvatorelli E; Menna P
    J Pharmacol Exp Ther; 2010 Jul; 334(1):2-8. PubMed ID: 20335321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotoxicity: cisplatin and long-term cancer survivors.
    Patanè S
    Int J Cardiol; 2014 Jul; 175(1):201-2. PubMed ID: 24820740
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiotoxicity after childhood cancer: beginning with the end in mind.
    Lipshultz SE; Adams MJ
    J Clin Oncol; 2010 Mar; 28(8):1276-81. PubMed ID: 20142585
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardio-Oncology: An Update on Cardiotoxicity of Cancer-Related Treatment.
    Lenneman CG; Sawyer DB
    Circ Res; 2016 Mar; 118(6):1008-20. PubMed ID: 26987914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing cardio-oncology programs for cancer patients.
    Francis SA; Asnani A; Neilan T; Scherrer-Crosbie M
    Future Oncol; 2015; 11(14):2011-5. PubMed ID: 26198828
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy-induced cardiovascular toxicity: beyond anthracyclines.
    Ai D; Banchs J; Owusu-Agyemang P; Cata JP
    Minerva Anestesiol; 2014 May; 80(5):586-94. PubMed ID: 24122036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management.
    Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM
    CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac complications in childhood cancer survivors treated with anthracyclines.
    Franco VI; Lipshultz SE
    Cardiol Young; 2015 Aug; 25 Suppl 2():107-16. PubMed ID: 26377717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting and preventing the cardiotoxicity of cancer therapy.
    Anderson B; Sawyer DB
    Expert Rev Cardiovasc Ther; 2008 Aug; 6(7):1023-33. PubMed ID: 18666852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New avenues in cardio-oncology.
    Sala V; Li M; Ghigo A
    Aging (Albany NY); 2019 Feb; 11(4):1075-1076. PubMed ID: 30728321
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardio-Oncology-Beyond Anthracyclines and Ejection Fraction.
    Geenty PD; Gregory AT; Nolan M; Denniss AR; Pepe S; Sverdlov AL; Thomas L
    Heart Lung Circ; 2024 May; 33(5):547-552. PubMed ID: 38823894
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiotoxicity: trastuzumab and cancer survivors.
    Patanè S
    Int J Cardiol; 2014 Dec; 177(2):554-6. PubMed ID: 25205483
    [No Abstract]   [Full Text] [Related]  

  • 14. Abnormal NT-pro-BNP levels in asymptomatic long-term survivors of childhood cancer treated with anthracyclines.
    Mavinkurve-Groothuis AM; Groot-Loonen J; Bellersen L; Pourier MS; Feuth T; Bökkerink JP; Hoogerbrugge PM; Kapusta L
    Pediatr Blood Cancer; 2009 May; 52(5):631-6. PubMed ID: 19127569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy-induced cardiotoxicity: new insights into mechanisms, monitoring, and prevention.
    Cadeddu Dessalvi C; Deidda M; Mele D; Bassareo PP; Esposito R; Santoro C; Lembo M; Galderisi M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2018 Jul; 19(7):315-323. PubMed ID: 29708912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to Prevent Cardiotoxicity.
    Graffagnino J; Kondapalli L; Arora G; Hawi R; Lenneman CG
    Curr Treat Options Oncol; 2020 Apr; 21(4):32. PubMed ID: 32270293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardioprotection in cancer therapy: novel insights with anthracyclines.
    Raber I; Asnani A
    Cardiovasc Res; 2019 Apr; 115(5):915-921. PubMed ID: 30726931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer drugs and cardiotoxicity: Insights and perspectives in the era of targeted therapy.
    Raschi E; Vasina V; Ursino MG; Boriani G; Martoni A; De Ponti F
    Pharmacol Ther; 2010 Feb; 125(2):196-218. PubMed ID: 19874849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticancer agents and cardiotoxicity.
    Ng R; Better N; Green MD
    Semin Oncol; 2006 Feb; 33(1):2-14. PubMed ID: 16473642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anthracycline cardiotoxicity in childhood.
    Ruggiero A; Ridola V; Puma N; Molinari F; Coccia P; De Rosa G; Riccardi R
    Pediatr Hematol Oncol; 2008 Jun; 25(4):261-81. PubMed ID: 18484471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.